기본 정보
- 표준 SMILES
N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O- InChIKey
LEVWYRKDKASIDU-IMJSIDKUSA-N- 분자식
- C6H12N2O4S2
- 평균 분자량
- 240.3 g/mol
- 단동위원소 질량
- 240.02384886
개요
L-cystine is the L-enantiomer of the sulfur-containing amino acid cystine. It has a role as an EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor, a flour treatment agent, a mouse metabolite, a Saccharomyces cerevisiae metabolite and a human metabolite. It is a cystine, a non-proteinogenic L-alpha-amino acid and a L-cysteine derivative. It is a conjugate acid of a L-cystine anion. It is an enantiomer of a D-cystine. It is a tautomer of a L-cystine zwitterion.
이름 및 식별자
- 우선 이름
- (-)-Cystine
- IUPAC
- (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
56-89-3、923-32-0- PubChem CID
- 67678
- DTXSID
DTXSID2046418- ChEMBL
CHEMBL590540- ChEBI
CHEBI:16283- UNII
- 48TCX9A1VT
- EC Number
- 200-296-3
- Nikkaji
- J9.172C
물성
구조 계산 물성
- XLogP
- -6.3
- 극성 표면적
- 177 Ų
- 수소 결합 공여자 수
- 4
- 수소 결합 수용자 수
- 8
- 회전 가능 결합 수
- 7
- 무거운 원자 수
- 14
- 형식 전하
- 0
- 복잡도
- 192
실험 및 물리화학적 성질
Cosmetics
Cosmetic ingredients (Cystine) -> CIR (Cosmetic Ingredient Review)
Antistatic; Hair conditioning
Physical Description
Solid; [Merck Index] White powder; [Sigma-Aldrich MSDS]
Solid
Collision Cross Section
145 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]
148.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
147.3 Ų [M+Na-2H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
149.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
150.08 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]
151.5 Ų [M+Na]+
안전 및 규제
GHS 분류
GHS Classification
This chemical does not meet GHS hazard criteria for 97.8% (182 of 186) of all reports.
Not Classified
Aggregated GHS information provided per 186 reports by companies from 5 notifications to the ECHA C&L Inventory.
유해성 정보
Regulatory Information
Chemical: L-Cystine
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Status: Active Update: 13-09-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/5911
L-cystine: Does not have an individual approval but may be used under an appropriate group standard
Cystine: Does not have an individual approval but may be used under an appropriate group standard
독성 정보
화학 및 산업
약리 정보
Pharmacodynamics
L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.
용도 및 제조
Uses
CIR ingredient: Cystine
A non-essential amino acid (a dimerization of two cysteine molecules); [Merck Index] Used as a flavoring agent, dough strengthener, and nutritional supplement for foods; [FDA]
Use (kg; approx.) in Germany (2009): >500
관련 반응
연결된 노트
불러오는 중…